StockMirror — Stock Screener

EMAMILTD Q2 FY27 Results & Earnings Analysis

Sentiment: Good (Confidence: high)

Earnings Summary

Emami delivered strong Q2 FY27 performance with consolidated revenue growth of 36% to INR1,088 crores (24% like-to-like) and domestic volume growth of 43% (26% like-to-like). Core brands fired across categories: skincare +31%, hair and scalp care +30%, healthcare +11%. Strategic investments (Axiom, IncNut, Brillare, The Man Company) grew 73% like-to-like and now contribute ~26% of domestic business. Gross margin declined 520 bps (400 bps from input costs, 120 bps from mix), but cost management delivered 25% EBITDA growth to INR222 crores and 29% PBT growth to INR194 crores. PAT declined 3% to INR144 crores due to tax rate normalization. International declined 2% due to Nepal floods and Gulf/Iraq supply chain issues but is now back in green territory. Management upgraded strategic investments guidance to INR850+ crores and expects 18-20% growth in H2. Balance sheet actions included INR281 crores buyback and INR214 crores interim dividend. Key risks are commodity inflation, geopolitical disruptions, and rural demand volatility in some regions.

Management Tone

Revenue Growth Drivers

Growth vs Margin Focus

Management explicitly stated focus is on growing top line: 'After many, many quarters, we are seeing our domestic business particularly our core portfolio firing in many, many brands. So at this point of time, we are not really thinking of 0.5%, 1% here and there. Wherever we are finding opportuniti

About Emami Limited

Emami Limited (EMAMILTD) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.

Explore More